Reducing Risks For Esophageal Cancer

Barrett’s esophagus patient’s risk for developing esophageal cancer has been shown to be reduced by aspirin and esomeprazole combination, according to results of a phase III ASPECT trial.

Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *